Pharmaceutical Business Review
Anonymous User | Login

Unilife Medical Solutions Amends Merger Implementation Agreement With Unilife USA

Published: 04-Nov-2009

To facilitate the proposed redomiciliation of the Unilife group in the USA

Unilife Medical Solutions (Unilife Australia) has entered into a merger implementation agreement with Unilife Corporation (Unilife USA) to facilitate the proposed redomiciliation of the Unilife group in the US.

The company has stated that the board established a consolidation ratio that provided a level of security against any decline, which might occur in both the Australian dollar exchange rate and the Unilife share price.

Thus, it was originally resolved that upon implementation of the proposed transaction, Unilife Australia's issued capital would be effectively consolidated by adopting a ratio of 12:1 that would provide the desired level of flexibility to meet NASDAQ minimum price policies and satisfy expected investor requirements in the United States.

However, the rise in the share price of Unilife Australia, and its subsequent stabilisation, coupled with the rise in the Australian dollar’s exchange rate versus the US dollar, has resulted in the Unilife board deciding to target a higher US dollar listing price and to revise the consolidation ratio adopted under the merger implementation agreement.

Accordingly, the board has now resolved to adopt a 6:1 ratio to effectively consolidate the share capital upon the redomiciliation of the Unilife group.

As a result, Unilife Australia and Unilife Corporation have amended the Merger Implementation Agreement to reflect the new consolidation ratio.

Mail sent successfully

Tell your friend about this article


Please enter a valid email address

Please enter your name

Please enter the mail body


Your Name: *
Your Email: *
Friend's Email: *
Email Body: *
 

Suppliers To This Sector

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Almac

Drug Development Solutions ...

STARLIMS

Benefits for Life Science Labs ...

Parenteral Drug Association (PDA)

Pharmaceutical Information and Education Services ...

Burkert Fluid Control Systems

Fluid and Gas Control Systems ...

IMCOR

LIMS and Laboratory Informatics Consultancy ...

Umicore Precious Metals Chemistry

Chemicals and Catalysts for Industrial Applications ...

White Papers

Browse A-Z

# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

GRACO's New FDA Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New Hydra-Clean

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

GRACO's New 1590 & 3150 Pumps

The Graco 3150 3A sanitary pump is designed to meet the stringent sanitation requirements ...

Water Treatment

From the control room to the downstream processing area and with an eye on utilities servi ...

Customer Testimonial – Astra Zeneca

From the control room to the downstream processing area and with an eye on utilities servi ...

Hygienic Processing

From the control room to the downstream processing area and with an eye on utilities servi ...

Related Companies

No items to display

Suppliers Product News

Almac Completes Phase One of Its Expansion Plan to Pharma Services Facilities

New $15m facility will "meet growing business need for its integrated product development and commercial services."

Free Newsletter Sign-up

Sign up, and we will send you a free Pharmaceutical report on “ Combination Products – Evolution of the Medical Equipment Industry” from GlobalData worth $750

Please enter a valid email address